GGB to Launch Greg Norman CBD Personal Care Products
CLS Holdings USA Inc. Included in LD Micro Index Rebalance
Cannabis and Tech Plays to Watch
Green Growth Brands Partners with Simon Property Group to Launch America's First Chain of CBD Shops
Should You Consider Cannabis Stocks after the Recent Rally?
Should You Invest in the First Trust Consumer Discretionary AlphaDEX Fund (FXD)?
Helix TCS: A Clear Market Leader in Cannabis Ancillary Services-- CFN Media
VIVO Cannabis Announces Cannabis Oil Sales License Granted to Wholly-Owned ABcann Medicinals
Pot Stocks Earnings This Week: What to Watch for
[$$] Colgate replaces Ian Cook as chief executive
[$$] Smith & Nephew leads European stock decliners on acquisition talk
Cannabis earnings: Pot stocks’ downturn may drown Aurora and others in red ink
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against 22nd Century, Vale, Revolution Lighting, and Astec and Encourages Investors to Contact the Firm
Could Canopy Growth Could Become Larger Than Constellation Brands?
Could OrganiGram Holdings Be a Millionaire-Maker Stock?
3 Legal Marijuana States Are Banning CBD Edibles. Here's Why.
3 Top Marijuana Stocks to Watch in February
Pot, soda and videogame earnings are on Wall Street’s to-do list
How marijuana companies can profit without selling pot
This Could Be the Next Marijuana Stock to Take Off (Hint: It's Not Canopy Growth)
What to Expect When the Biggest Pot Stocks Report Earnings This Week
Better Buy: Medical Marijuana vs. CV Sciences
What Now for Aphria After Its Board Tells Green Growth to Take a Hike?
Hemp vs. Marijuana: What’s the Difference?
Scotts Miracle-Gro vs. Innovative Industrial Properties: Which Is the Better Pot Play?
Better Marijuana Stock: Canopy Growth vs. KushCo Holdings
Better Marijuana Stock: Origin House vs. HEXO
Critical Quarterly Updates Ahead for Aurora Cannabis and Canopy Growth -- Here's What You Can Expect
How to tell when a marijuana-stock rally is real or a mirage
Smith & Nephew plc (LON:SN.): Financial Strength Analysis
Smith & Nephew in talks to buy NuVasive for over $3 billion - FT